Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade.
Frederik A VerburgGlenn FluxLuca GiovanellaDouglas van NostrandKristoff MuylleMarkus LusterPublished in: European journal of nuclear medicine and molecular imaging (2019)
Literature published in the last decade offers data that support adjuvant postoperative RIT in DTC patients with a tumor diameter exceeding 1 cm. Therefore, at least until randomized prospective studies prove otherwise, the prescription of adjuvant I-131 treatment to all DTC patients with a primary tumor diameter exceeding 1 cm remains a reasonable option.